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AbstrACt
Objectives Patient and public involvement (PPI) is argued 
to lead to higher quality health research, which is more 
relatable to and helps empower the public. We synthesised 
the evidence to look for examples of PPI in health research 
in low/middle-income countries (LMICs), looking at levels 
of involvement and impact. Additionally, we considered the 
impact of who was undertaking the research on the level 
of involvement and reported impact.
Design Systematic review.
Data sources EMBASE, Medline and PsychINFO, along 
with hand-searching references, grey literature, Google 
search and expert advice.
Eligibility criteria Any health research with evidence of 
patient or public involvement, with no language restrictions 
dated from 1978 to 1 Dec 2017.
Data extraction and synthesis Data relating to stage 
and level of involvement, as well as impact, were extracted 
by one researcher (NC), and a coding framework was 
developed using an inductive approach to examine the 
impact of PPI on research. Extracted data were then 
independently coded by a second lay researcher (RK) to 
validate the data being collected. Discrepancies were 
referred to a third independent reviewer (MT) for review 
and consensus reached.
results Sixty-two studies met the inclusion criteria. 
The review revealed the most common stage for PPI 
was in research planning, and the most common level 
of involvement was collaboration. Most studies did not 
provide evidence of effectiveness or elaborate on the 
impact of PPI, and they tended to report impact from the 
researcher’s perspective. Where impact was mentioned, 
this generally related to increased relevance to the 
community, empowerment of participants and alterations 
in study design.
Conclusions The literature describing approaches to and 
impact of PPI on LMIC health research is sparse. As PPI 
is essential to conducting high-quality research, it should 
be fully reported and evaluated at the end of the research 
project. 
bACkgrOunD
rationale
Patient and public involvement (PPI) in 
research has been defined as ‘research being 
carried out 'with' or 'by' members of the 
public, rather than 'to', 'about' or 'for' them’.1 
The global mandate for public involvement 
was set by the World Health Organisation 
Declaration of Alma-Ata in 1978, as a step 
towards everyone having the ‘right and duty 
to participate individually and collectively in 
the planning and implementation of their 
healthcare’.2 
Developing stronger PPI in the research 
and delivery of healthcare is now a central 
component of research proposals for 
funders in high-income countries (HICs), 
for example, the INVOLVE framework in 
the UK, which has been well established for 
over two decades. Patients and the public can 
be actively involved in research throughout 
the research cycle, and this can lead to 
higher quality health research, which meets 
the needs of the target community, and is 
relatable to and helps empower the public. 
strengths and limitations of this study
 ► We conducted an extensive systematic search of the 
literature, along with hand searching; grey literature 
searches were limited, however, to a Google search 
and expert advice due to resource constraints.
 ► Varying use of terminology relating to  patient 
and public i nvolvement (PPI) over time and across 
disciplines may mean that some pertinent literature 
may not have been identified. The literature search 
was further complicated by the lack of  Medical 
Subject Headings (MeSH) terms in database 
searches.
 ► We did not have the resources to seek further in-
formation from authors, so data were restricted to 
published information. Furthermore, the literature 
search was conducted in December 2017, so recent 
research may be missed.
 ► None of the papers identified or reported the impact 
of PPI from the perspective of the patient or the pub-
lic, and so any perceived benefits or challenges from 
these perspectives are missing from the existing 
literature. Furthermore, papers tend to report PPI 
within the context of study results, so these  often 
lack details in their reporting.
 ► Publication and reporting biases might have an im-
pact on the findings of this review, but their impact 
cannot be estimated.
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However, there are concerns that mandating PPI in 
grant applications can lead to ‘tokenistic involvement’, 
with academics involving patients and public in research 
grants simply for funding purposes, without commit-
ment to embedding them into the research.3 The issue 
of tokenism seems to become even more acute when 
considering research undertaken in low/middle-income 
countries (LMICs).
As the emphasis on PPI in research continues to grow 
in HICs, the extent and impact of PPI in LMICs remains 
unclear. Research is becoming increasingly globalised, 
with researchers from HICs operating on an interna-
tional basis, particularly in LMICs. This research is often 
supported by smaller local funders, who may not have the 
same requirements for PPI. HIC-based health research 
funders expect researchers to engage with the new 
well-established international, national and institutional 
sources of guidance about how to undertake research 
in LMICs, not the least the World Medical Association’s 
Declaration of Helsinki.4 This has led to a move to recog-
nise the importance of both economic and cultural 
differences, and so the importance of identifying locally 
sustainable solutions.
To our knowledge, there has been one previous attempt 
to systematically analyse examples of PPI in research in 
LMICs. Semrau et al conducted a systematic review on 
service user involvement in mental health system strength-
ening, concluding that there was no evidence on how 
best to involve service users in mental health research in 
LMICs.5 In our review, we broadened the search criteria 
to capture PPI from the whole of health research and also 
identified examples of PPI, which may be described using 
a different terminology.
Recently, there has been a growing interest in PPI in 
LMICs with the launch of the ‘International Network 
for Public Involvement and Engagement in Health and 
Social Care Research’ from Cochrane6 and INVOLVE’s 
National Institute for Health Research (NIHR) Interna-
tional Network7 to drive PPI forward.
Given this drive to improve PPI in LMICs, it is timely to 
review the evidence on this important topic. The aim of 
this systematic review is to describe the PPI strategies and 
their impact reported in health research in LMICs in a 
narrative synthesis of the literature.
MEthODs
Eligibility criteria
Inclusion criteria included
 ► Any study design.
 ► Health research.
 ► Any age of study participants.
 ► Any language.
 ► 1978–1 December 2017 (the inception date coincides 
with WHO Declaration of Alma-Ata).
 ► Evidence of patient or public involvement in research.
search strategy and study selection
A literature search was performed using EMBASE, Medline 
and PsychINFO, along with hand-searching references of 
key articles and a Google search and expert advice for grey 
literature. After consideration, it was decided to include 
a wide range of terminologies to capture studies that had 
PPI but did not necessarily define it as such. For example, 
community-based participatory research (CBPR) and 
participatory action research (PAR) are commonly used 
in research, and when the other inclusion criteria were 
met, these studies were included in the analysis. CBPR is a 
term used to describe research that ideally stems from the 
local community and continues to involve all partners, in 
an equal way, throughout the entire research process, 
and so closely aligns to ‘user-led’ research.8 Similarly, 
the term PAR is commonly used to describe an approach 
that involves ‘researchers and participants working 
together’, often focusing on social change.9
Studies focusing only on community engagement 
were excluded unless they specifically included mention 
of patient or public involvement in the study design or 
conduct. Community engagement is where ‘information 
and knowledge about research is provided or shared’, for 
example, open meetings to raise awareness or using social 
media to share findings.10 Furthermore, since the study 
design or topic was not our focus, we included studies of 
any design from all disciplines; information about PPI 
may be relevant for health research regardless of study 
type or discipline.
Search terms were decided with the help of an informa-
tion specialist (KW), checking for inclusion of key papers 
known to the team and refining the balance between 
feasibility and inclusivity. Search terms included
Patient & Public (patient, public, service-user, care-giver, 
family, consumer, lay person, advocacy group, NGO, 
citizen, community, client, consumer, survivor, stake-
holder, relative)
AND
Involvement (community participation, patient partic-
ipation, community based participatory research, PPI, 
collaborat*, engag*, partner*)
AND
Low and Middle-Income Country (developing country, list 
of individual countries as per World Bank – Jan 2018)
AND
Health Research (health services research, biomedical 
research, research design, qualitative)
DAtA ExtrACtiOn AnD CODing
All studies meeting the inclusion criteria were read in 
full by one researcher (NC), and relevant data, relating 
to stage and level of involvement as well as impact, were 
extracted using a structured data extraction sheet and 
a coding framework was developed using an inductive 
approach to examine the impact of PPI on research. 
Extracted data were then independently coded by a 
second lay researcher (RK) to validate the data being 
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collected. Discrepancies in how the coding framework 
was applied to extracted data were referred to a third 
independent reviewer (MT) for review and consensus 
reached.
In this review, categories for stages of the research 
cycle were based on those described by the NIHR (see 
figure 1)11:
For coding purposes, stages were categorised 
into four groups: pre-research (identifying, priori-
tising and commissioning); planning (designing and 
managing); undertaking research (undertaking); post-
research (disseminating, implementing and evaluating 
impact). Levels of involvement were coded using NIHR 
definitions12:
1. Consultation, which is asking the public for their views 
and using them to inform decision making.
2. Collaboration, which consists of an ‘ongoing partner-
ship’ between research teams and members of the pub-
lic, ‘where decisions about the research are shared’.
3. User-controlled research, which is ‘actively controlled, 
directed and managed by’ the public.
No quality assessment was performed on the studies, 
since the purpose of the review was to identify strategies 
and the impact of PPI rather than focus on the type or 
the quality of the study undertaken. However, in order to 
assist with the interpretation of the results, we extracted 
key information relating to research design (see online 
appendix 1).
Finally, as part of the review, we designed and led 
a workshop attended by LMIC partners from the 
Improving Mental and Physical Health Multimorbidity 
and Developing Research Capacity (IMPACT) Group on 
7 December 2018 in York. In this, we presented our find-
ings and led a group discussion covering PPI terminology, 
recruitment strategies and ways of reporting impact, all of 
which will feed into the IMPACT study design.
PAtiEnt AnD PubliC invOlvEMEnt
This narrative review was supported by RK, who is a lay 
researcher who assisted as an independent coder and 
author. Additionally, LMIC partners from IMPACT 
reviewed the findings and contributed to the discussion, 
as described above.
rEsults
A total of 1969 studies were identified in the literature 
search (see figure 2 for Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) flow 
diagram). After duplicate removal, 1314 abstracts (and 
full papers, if required) were screened based on the inclu-
sion criteria by one researcher (NC), resulting in 1184 
studies being excluded (see figure 3 for details of exclu-
sion criteria). A total of 61 studies from 34 different coun-
tries were included in the narrative synthesis (see online 
appendix 1 and 2).
Many of the included studies identified their method as 
CBPR (n=26) or PAR (n=11). The majority of the papers 
were primary research; either developing or piloting inter-
ventions (n=20), qualitative research (n=17), research 
methods/design (n=6) or research priorities (n=4). In 
these papers, discussion of PPI was generally secondary to 
reporting the study results and often comprised only a few 
sentences scattered throughout the paper. The remaining 
papers were reflections on research (n=14), particularly 
focused on community advisory boards and researcher 
experiences. None of the studies identified would meet 
the criteria of the only agreed reporting framework for 
PPI, the Guidance for Reporting Involvement of Patients 
and the Public (GRIPP)2 checklist.13
Figure 1 National Institute for Health Research research 
cycle.
Figure 2 Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses  flow diagram.
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The review found that the most common stage to have 
PPI was the planning stage (n=51) followed by undertaking 
(n=30), postresearch (n=27) and, finally, pre-research 
(n=18). Regarding level of involvement, 37 studies were 
classed as collaboration, with only 4 being classed as user 
controlled and 20 as consultation (see online appendix 
1). Most studies took place in the African subcontinent, 
followed by India. Using World Bank criteria, the coun-
tries where the research took place could be classified as 
low-income countries (n=8), lower middle-income coun-
tries (n=15) and upper middle-income countries (n=11)14 
(see online appendix 2).
Studies with consultation-level involvement often had 
some form of community advisory committee that was 
used to inform the community about different aspects 
of the research and sometimes seek their opinion on 
the research objectives, design and implementation. 
Mushi et al describe presenting preliminary findings and 
intervention packages in village meetings as part of the 
consultation process.15 Similarly, Owolabi et al reports 
using a task force that included representatives of the 
Nigerian Stroke Society to ‘review the progress of the 
community participatory research process and make 
recommendations about any local adaptations to facili-
tate its effectiveness’.16
Collaboration-level involvement had varying strategies; 
some studies described a partnership between researcher 
and advocacy groups that ensured ongoing, two-way 
engagement between the community and the research 
team, with the community identifying the healthcare 
problem and driving forward solutions. Bradley and 
Puane research started after the community voiced 
concerns to community health workers (CHWs) about 
the increasing prevalence of hypertension and diabetes 
in their community.17 Following this, a meeting was held 
with the local community health committee and commu-
nity leaders. Aims were formulated with the intention of 
engaging CHWs in many aspects of the research process, 
including data collection, analysis and dissemination. 
Zola et al reported that the ‘community based organisa-
tion members (CBO), people living with HIV (PLHIV) 
and researchers were involved, in an equitable partner-
ship’.18 Community members were trained in research 
methods and ethics, and then involved in developing the 
questionnaire and conducting the interviews.18
Finally, looking at user-controlled research, common 
strategies included community-initiated research, involve-
ment in the entire research project, from pre-research 
through to evaluation and ongoing involvement from 
peer researchers.19–22 Hayashi et al describe CBPR, which 
was led by a group of active and former drug users (Thai 
Drug Users’ Network) who were involved in the whole 
study from design to analysis and dissemination.22 Simi-
larly, Jongudomkarn’s study was initiated by community 
members via a forum, and the women were involved in 
the entire research process right through to the action 
plan and evaluation.21
The most commonly cited impacts of PPI included 
increased relevance to the community, empowerment 
of participants and alterations in trial design. Foster et al 
reported that the research team, consisting of US nurses, 
Dominican nurses and community leaders, continued 
to meet after the research had ended to drive improve-
ment, hence empowering the team.23 After the conclu-
sion of Jongudomkarn’s research, the women involved 
became the ‘resource persons responsible for alcohol 
consumption campaigns’.21 Liu et al explained that the 
community steering group modified the wording of 
some of the translations to ensure cultural relevance 
for a Mandarin-speaking population.24 Following feed-
back from the community reference team, Mosavel et al 
decided to ‘refocus the research from cervical cancer to 
"cervical health"’.25
Another benefit reported was improved quality of 
results; Bowling et al commented that the ‘partnership 
with local researchers and community partners strength-
ened the quality of the findings through their involve-
ment in design, recruitment and interpretation phases’.26 
Reflecting on higher levels of engagement in the commu-
nity, Grinker et al described how PPI ‘facilitates the 
crucial recruitment phase as well as participant retention 
by limiting or managing negative views or misunder-
standings of the researchers, procedures or goals of the 
study’.27 Another impact to consider is increased commu-
nity trust and improved community-researcher relations. 
In Simwinga et al ’s South African study, community 
advisory board members provided a ‘protective role for 
community members’ and also helped ‘resolve tensions 
between researchers and community’.28 Furthermore, PPI 
can help challenge common community misconceptions 
and stigma; Adhikari et al noted that having local villagers 
involved in their malaria study helped tackle rumours 
Figure 3 Exclusion criteria. LMIC, low/middle-income 
country; PPI, patient and public involvement. 
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in the community.29 Finally, some studies reported on 
the difficulties of PPI, largely focusing on the extra time 
and money required to have PPI in their study.22 30–32 It 
is important to note that most of the impact reported is 
from the researcher’s perspective and was often reported 
as an aim rather than an evidence-based outcome of PPI. 
In some cases, impact was not reported at all.
We thought it was important to consider whether 
the study authors were from the study country. The 
vast majority of studies (93%, n=57) had at least one 
author from the study country; 43 of these were in part-
nership with researchers from HICs. Only five studies 
were conducted without the input of local researchers. 
Although it is difficult to be certain from study reports, we 
estimate 10 of the 61 studies included non-governmental 
organisation or advocacy group members as authors.
Finally, we struggled to find funding guidance to identify 
whether PPI was a required component of the research. 
Some of the larger international funders mention public 
engagement as a concept in their material.33–36 However, 
many of the studies were funded by smaller local funders, 
for whom we were unable to find guidance.
DisCussiOn
This review is the first to systematically review PPI in health 
research in LMICs. None of the studies made explicit 
reference to PPI as a term nor did they refer to the use 
of any tools or funding requirements. This could reflect 
an actual lack of PPI but may also reflect that research 
teams are simply not reporting PPI in research publi-
cations, or that researchers are using a different termi-
nology for involvement activities. It is important to state 
that the poor reporting of PPI is not unique to research 
conducted in LMICs. Both Mockford et al and Brett have 
identified issues with the evidence base behind PPI, as 
well as the poor quality of reporting, which is essentially 
limiting our understanding of PPI impact on HICs.37 38
Nevertheless, the findings reveal that researchers are 
using PPI at different stages and levels in health research 
taking place in LMICs, highlighting that regardless of 
the subject, type or location of research, PPI can be inte-
grated into the research process and may consequently 
have an impact on both the research and the individuals 
involved. There is a lack of reporting of PPI strategies and 
impact; those studies that do are still largely reporting 
impact from the researcher's perspective.
Earlier research looking at the impact of PPI in the 
USA, UK and Europe aligns closely with the findings of 
our review of LMICs, suggesting that although the context 
may be quite different, benefits can be realised from PPI 
in LMIC. Brett et al discuss the impact of PPI throughout 
the research cycle, suggesting that PPI in the planning 
stage can help identify and prioritise topics according to 
relevance; in the implementation stage, it can help partic-
ipant recruitment and researcher–participant rapport, 
and during analysis and write-up, it allows findings to be 
interpreted from a user perspective and can also assist 
with research dissemination.39
Our review identified that most PPIs in LMICs take 
place during the planning stage of research, which is in 
contrast to a similar review, not focused on LMIC, which 
found more examples of PPI in the execution phase.40 It is 
difficult to say definitively why this might be the case, but 
it may be related to non-LMIC researchers recognising 
the need to gain local knowledge in planning research in 
relatively unfamiliar settings.
PPI for many studies involved the setting up of commu-
nity advisory groups/boards, but it is not clear if this is the 
most appropriate source of PPI or whether the formation 
of these groups acts as a barrier to meaningful engage-
ment with the end user of the research, as the members of 
these groups were local community leaders, rather than 
those living with the particular health problem.
Furthermore, the involvement of local researchers was 
also apparent in the studies identified. This provided 
research teams with a mechanism to liaise at a grass 
roots level with local leaders in their local dialects and 
to remain alert to local sensitivities. In addition, LMIC 
researchers may gain an advantage by identifying topics 
relevant to the community and by gaining access and 
acceptance into the community, ultimately enabling 
the progression of the research project; this could also 
be used as a useful opportunity for research capacity 
building, which was mentioned in a couple of included 
studies.22 41 The overall relatively low level of patient 
involvement across the research cycle may be due to the 
importance, or lack of it, that funders place on PPI. Many 
of the studies reported in our review were supported by 
universities or smaller funders, for whom we were unable 
to find funding guidance. Larger, national and interna-
tional funders do provide information about engaging 
communities but tend not to use the term ‘patient involve-
ment’; rather they focus more on public engagement, 
which, as a concept, has some overlap with community 
engagement and PPI. For example, National Institutes of 
Health, USA, encourages community engagement as a 
‘process of working collaboratively’.34 Similarly, guidance 
issued by the Australian Government Research Award 
Scheme emphasises the importance of ‘research engage-
ment and communication’,35 and the UNC Centre for 
AIDS Research has a ‘Strategic Community Engagement 
Education Dissemination Office’,36 with similar aims.
It is therefore unsurprising that researchers focus on 
the engagement of community leaders as this aligns with 
those goals, rather than engaging with research partic-
ipants. What is unclear in the literature from LMICs is 
whether these were the goals of PPI in these studies, 
or incidental benefits. The rationale given by many of 
these researchers for involving people at the design stage 
is often related to ensuring that gatekeepers support 
the research and facilitate access to the population 
of interest, rather than to improve the quality of the 
research per se.42–44 Many of the studies included in the 
review describe research in populations that would be 
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defined as hard-to-reach groups, such as people with or 
at risk of HIV/AIDS, people with mental health problems 
(eg, schizophrenia) and people with drug/alcohol prob-
lems. In the UK, there is now a long-established literature 
setting out both consumerist and democratic reasons for 
involving patients and the public in research.45 It could 
be argued that in at least some of the studies, we found 
that a third reason dominated, and that was pragmatism.
Considering ways of increasing potential for impact, 
Brett et al reflected that good training and having clearly 
defined roles, in a positive supportive environment with 
mutual trust and respect would be beneficial.39Simi-
larly, the EPIC study encourages researchers to set clear 
goals and well-developed plans and to advocate for indi-
viduals to be involved early in the research in a respon-
sive, managerial way rather than solely to have a general 
oversight, more often seen in membership of a steering 
committee (the latter approach was widely used in the 
studies we identified in our review).46 Since many of the 
studies included in our review were CBPR, there was 
often a more hands-on type of involvement from partici-
pants, for example, trained community members taking 
on the role of researcher47–49 and participants shaping/
piloting interventions50 51; this type of involvement will 
also fulfil the secondary aim of engaging participants in 
the research and perhaps develop local research capacity.
Finally, lack of standardisation in designing and eval-
uating PPI frameworks and strategies means it is diffi-
cult for researchers to develop a comprehensive PPI 
strategy. Over the last decade, researchers have been 
developing PPI toolkits but as yet, none have been 
adopted as a standardised tool.52–54 One of the more 
recent is the GRIPP2 checklist, which was developed 
following a systematic review and Delphi study to assist 
with the reporting of PPI in research, with the aim of 
improving quality and transparency of the PPI evidence 
base.13 The authors recommend that the checklist 
should be used prospectively in research design and 
retrospectively in evaluation. The GRIPP2 short form 
includes sections on aims, method, results (both posi-
tive and negative), discussion (impact) and reflection, 
each of these areas requiring information specific to 
PPI.13 However, it is important to note that this tool, 
though developed for international use, was developed 
from an HIC perspective, and though there are similar-
ities, there are also complexities specific to LMIC that 
need to be considered, particularly the variations in 
research infrastructure, cultural differences, the power 
differential between researcher and researched in these 
contexts, and often, lower research budget. Other than 
cultural differences and research budget, none of the 
other areas were explicitly considered in the included 
studies.
The review suggests that there are positive gains to 
be had from involving communities from LMICs in 
research, and the complexities faced by LMIC research 
are things that PPI can help with, through facilitating 
communication with communities28 55 and adapting 
interventions for different cultures.50 56 PPI is still rela-
tively new, even in countries with a well-established 
research tradition; it may take time for it to gain trac-
tion in countries without this tradition.
COnClusiOn
From this study, we can conclude that PPI does happen 
in LMIC health research but is generally described using 
a different terminology and rarely are detailed PPI strate-
gies published. Similarly, at present the impact of PPI on 
both the participant and research is poorly documented. 
There is significant work needed to encourage closer 
engagement with end users of research, not just with 
community ‘gate-keepers’.
To improve this, LMIC research funders and journal 
publishers should make PPI an explicit requirement. 
Work also needs to be done on adapting pre-existing PPI 
tools for use in LMIC and encouraging their use, to clearly 
evidence the level, stage and impact of PPI. This will give 
researchers a generic format and space for reflection and 
will also capture the voice of the patient and the public to 
show how it has affected them as individuals, as well as the 
wider community.
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